Covered recipient · General Payments record
DEBRA ANN GAUTHIER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,310.40
- Reported across 190 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $490.96 | 31 |
| Education | $199.98 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $240.94 | 6 |
| ABBVIE INC. | $173.05 | 14 |
| Amgen Inc. | $88.83 | 4 |
| LEO Pharma Inc. | $27.72 | 1 |
| UCB, Inc. | $25.14 | 1 |
| Incyte Corporation | $24.29 | 1 |
| Regeneron Healthcare Solutions, Inc. | $23.61 | 1 |
| Dermavant Sciences, Inc. | $21.95 | 1 |
| Journey Medical Corporation | $21.27 | 1 |
| Galderma Laboratories, L.P. | $18.43 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.53 | 1 |
| Biofrontera Inc. | $12.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.66 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157776 | CMS |
| ABBVIE INC. | $4.62 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157778 | CMS |
| ABBVIE INC. | $5.82 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157780 | CMS |
| ABBVIE INC. | $8.79 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157782 | CMS |
| ABBVIE INC. | $20.93 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157784 | CMS |
| ABBVIE INC. | $6.03 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157786 | CMS |
| ABBVIE INC. | $12.88 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157788 | CMS |
| ABBVIE INC. | $26.09 | 10/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157790 | CMS |
| ABBVIE INC. | $9.26 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157792 | CMS |
| ABBVIE INC. | $16.97 | 10/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157794 | CMS |
| ABBVIE INC. | $8.97 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157796 | CMS |
| ABBVIE INC. | $16.49 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157798 | CMS |
| ABBVIE INC. | $10.17 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157800 | CMS |
| ABBVIE INC. | $5.37 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107157802 | CMS |
| Amgen Inc. | $23.83 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117560620 | CMS |
| Amgen Inc. | $26.84 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117560622 | CMS |
| Amgen Inc. | $22.54 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117560624 | CMS |
| Amgen Inc. | $15.62 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117560626 | CMS |
| Biofrontera Inc. | $12.18 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107927912 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13.53 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118108351 | CMS |
| Dermavant Sciences, Inc. | $21.95 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127974860 | CMS |
| Galderma Laboratories, L.P. | $18.43 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145359164 | CMS |
| Incyte Corporation | $24.29 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141299641 | CMS |
| Janssen Biotech, Inc. | $24.72 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078718953 | CMS |
| Janssen Biotech, Inc. | $99.99 | 04/11/2024 | Education | Undisputed | 01/23/2026 | 1078719004 | CMS |
| Janssen Biotech, Inc. | $3.67 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078718497 | CMS |
| Janssen Biotech, Inc. | $99.99 | 11/05/2024 | Education | Undisputed | 01/23/2026 | 1078718877 | CMS |
| Janssen Biotech, Inc. | $3.67 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078718893 | CMS |
| Janssen Biotech, Inc. | $8.90 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078718517 | CMS |
| Journey Medical Corporation | $21.27 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100053275 | CMS |
| LEO Pharma Inc. | $27.72 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152668773 | CMS |
| Regeneron Healthcare Solutions, Inc. | $23.61 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114305110 | CMS |
| UCB, Inc. | $25.14 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143177243 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.